The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial ...

The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...

EU chief, Trump had 'good exchange' by phone Sunday CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.

BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Citizen’s Petition Filed Requesting FDA Approve NurOwn™ On July 3, 2025, a Citizen’s Petition was filed with the U.S. Food and Drug ...

Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...

The FDA was particularly concerned about the selling of unapproved CBD products for food-producing animals. The FDA's Center ...